GW RESEARCH LIMITED v. TEVA PHARMACEUTICALS, INC. et al
GW RESEARCH LIMITED |
TEVA PHARMACEUTICALS, INC., APOTEX INC., PADAGIS US LLC, INVAGEN PHARMACEUTICALS, INC., CIPLA LTD., CIPLA USA, INC., API PHARMA TECH LLC, LUPIN LTD., ALKEM LABORATORIES LTD., TARO PHARMACEUTICAL INDUSTRIES LTD., ASCENT PHARMACEUTICALS, INC., MSN LABORATORIES PRIVATE LTD., MSN PHARMACEUTICALS, INC., ZENARA PHARMA PRIVATE LTD. and BIOPHORE PHARMA, INC. |
2:2023cv03914 |
July 21, 2023 |
US District Court for the District of New Jersey |
Andre M Espinosa |
Michael E Farbiarz |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. § 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on September 13, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 36 WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. ASCENT PHARMACEUTICALS, INC. waiver sent on 8/3/2023, answer due 10/2/2023. (LIZZA, CHARLES) |
Filing 35 NOTICE of Appearance by MICHAEL T. HENSLEY on behalf of API PHARMA TECH LLC, CIPLA LTD., CIPLA USA, INC., INVAGEN PHARMACEUTICALS, INC. (HENSLEY, MICHAEL) |
CLERK'S QUALITY CONTROL MESSAGE - Please be advised, when entering a substitution of Attorney in a case, counsel should add their name when prompted. The Clerks office has added MICHAEL HENSLEY, as representing Defendants Cipla USA, Inc., Cipla Ltd, InvaGen Pharmaceuticals, Inc. and API Pharma Tech LLC in this case. This submission will remain on the docket unless otherwise ordered by the court. This message is for informational purposes only. (jd, ) |
Filing 34 Substitution of Attorney - Attorney PAUL W. KALISH terminated.. (HENSLEY, MICHAEL) |
Pro Hac Vice counsel, STEPHEN R. AUTEN and PHILIP Y. KOUYOUMDJIAN, has been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (jd, ) |
Filing 33 Notice of Request by Pro Hac Vice Philip Y Kouyoumdjian to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14649883.) (FLAX, MELISSA) |
Filing 32 Notice of Request by Pro Hac Vice Stephen R. Auten to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14649809.) (FLAX, MELISSA) |
Filing 31 CONSENT ORDER granting #29 Defendant's Application for the Pro Hac Vice Admission as to STEPHEN R. AUTEN, ESQ. and PHILIP Y. KOUYOUMDJIAN, ESQ. Signed by Magistrate Judge Andre M. Espinosa on 9/6/2023. (dam) |
Filing 30 NOTICE of Appearance by MELISSA ELLEN FLAX on behalf of APOTEX INC. (FLAX, MELISSA) |
Filing 29 Letter from Melissa E. Flax to Hon. Andre M. Espinosa, U.S.M.J.. (Attachments: #1 Declaration of Stephen R. Auten in Support of Pro Hac Vice Admission, #2 Declaration of Philip Y. Kouyoumdjian in Support of Pro Hac Vice Admission, #3 Declaration of Melissa E. Flax in Support of Pro Hac Vice Admission, #4 Proposed Consent Order)(FLAX, MELISSA) |
Filing 28 NOTICE of Appearance by JAMES S. RICHTER on behalf of LUPIN LTD. (RICHTER, JAMES) |
Filing 27 WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. LUPIN LTD. waiver sent on 8/3/2023, answer due 10/2/2023. (LIZZA, CHARLES) |
Filing 26 WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. MSN LABORATORIES PRIVATE LTD. waiver sent on 8/3/2023, answer due 10/2/2023. (LIZZA, CHARLES) |
Filing 25 WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. MSN PHARMACEUTICALS, INC. waiver sent on 8/3/2023, answer due 10/2/2023. (LIZZA, CHARLES) |
Filing 24 WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. TEVA PHARMACEUTICALS, INC. waiver sent on 8/3/2023, answer due 10/2/2023. (LIZZA, CHARLES) |
Filing 23 NOTICE of Appearance by PAUL W. KALISH on behalf of API PHARMA TECH LLC, CIPLA LTD., CIPLA USA, INC., INVAGEN PHARMACEUTICALS, INC. (KALISH, PAUL) |
Filing 22 WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. TARO PHARMACEUTICAL INDUSTRIES LTD. waiver sent on 8/3/2023, answer due 10/2/2023. (LIZZA, CHARLES) |
Filing 21 WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. INVAGEN PHARMACEUTICALS, INC. waiver sent on 8/3/2023, answer due 10/2/2023. (LIZZA, CHARLES) |
Filing 20 WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. CIPLA USA, INC. waiver sent on 8/3/2023, answer due 10/2/2023. (LIZZA, CHARLES) |
Filing 19 WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. CIPLA LTD. waiver sent on 8/3/2023, answer due 10/2/2023. (LIZZA, CHARLES) |
Filing 18 WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. API PHARMA TECH LLC waiver sent on 8/3/2023, answer due 10/2/2023. (LIZZA, CHARLES) |
Filing 17 WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. PADAGIS US LLC waiver sent on 8/3/2023, answer due 10/2/2023. (LIZZA, CHARLES) |
Filing 16 NOTICE of Appearance by TIMOTHY P. GONZALEZ on behalf of TARO PHARMACEUTICAL INDUSTRIES LTD. (GONZALEZ, TIMOTHY) |
Filing 15 NOTICE of Appearance by GENE Y. KANG on behalf of TARO PHARMACEUTICAL INDUSTRIES LTD. (KANG, GENE) |
Filing 14 NOTICE of Appearance by GREGORY D. MILLER on behalf of TARO PHARMACEUTICAL INDUSTRIES LTD. (MILLER, GREGORY) |
Filing 13 NOTICE of Appearance by DMITRY V. SHELHOFF on behalf of ZENARA PHARMA PRIVATE LTD. (SHELHOFF, DMITRY) |
Filing 12 NOTICE of Appearance by DMITRY V. SHELHOFF on behalf of BIOPHORE PHARMA, INC. (SHELHOFF, DMITRY) |
Filing 11 WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. ALKEM LABORATORIES LTD. waiver sent on 8/3/2023, answer due 10/2/2023. (LIZZA, CHARLES) |
Filing 10 WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. ZENARA PHARMA PRIVATE LTD. waiver sent on 8/3/2023, answer due 10/2/2023. (LIZZA, CHARLES) |
Filing 9 WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. BIOPHORE PHARMA, INC. waiver sent on 8/3/2023, answer due 10/2/2023. (LIZZA, CHARLES) |
Filing 8 WAIVER OF SERVICE Returned Executed by GW RESEARCH LIMITED. APOTEX INC. waiver sent on 8/3/2023, answer due 10/2/2023. (LIZZA, CHARLES) |
Filing 7 NOTICE of Appearance by ALEXANDER LEE CALLO on behalf of GW RESEARCH LIMITED (CALLO, ALEXANDER) |
Filing 6 NOTICE of Appearance by SARAH ANN SULLIVAN on behalf of GW RESEARCH LIMITED (SULLIVAN, SARAH) |
Filing 5 NOTICE of Appearance by WILLIAM C. BATON on behalf of GW RESEARCH LIMITED (BATON, WILLIAM) |
Filing 4 AO120 Patent Form filed. (Attachments: #1 Complaint and Exhibit) (qa, ) |
Filing 3 SUMMONS ISSUED as to ALKEM LABORATORIES LTD., API PHARMA TECH LLC, APOTEX INC., ASCENT PHARMACEUTICALS, INC., BIOPHORE PHARMA, INC., CIPLA LTD., CIPLA USA, INC., INVAGEN PHARMACEUTICALS, INC., LUPIN LTD., MSN LABORATORIES PRIVATE LTD., MSN PHARMACEUTICALS, INC., PADAGIS US LLC, TARO PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS, INC., ZENARA PHARMA PRIVATE LTD.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (qa, ) |
Case Assigned to Judge Michael E. Farbiarz and Magistrate Judge Andre M. Espinosa. (ak, ) |
Filing 2 Corporate Disclosure Statement by GW RESEARCH LIMITED. (LIZZA, CHARLES) |
Filing 1 COMPLAINT against ALKEM LABORATORIES LTD., API PHARMA TECH LLC, APOTEX INC., ASCENT PHARMACEUTICALS, INC., BIOPHORE PHARMA, INC., CIPLA LTD., CIPLA USA, INC., INVAGEN PHARMACEUTICALS, INC., LUPIN LTD., MSN LABORATORIES PRIVATE LTD., MSN PHARMACEUTICALS, INC., PADAGIS US LLC, TARO PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS, INC., ZENARA PHARMA PRIVATE LTD. ( Filing and Admin fee $ 402 receipt number ANJDC-14474579) , Related Case Selected, filed by GW RESEARCH LIMITED. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(LIZZA, CHARLES) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.